Serum interleukin-4 is elevated in clinical drug-induced liver injury.
M N LiuM AuM BisharaThomas WorlandD ConS ChewA McNieceH GronbaekP SlukaA J NicollPublished in: Scandinavian journal of gastroenterology (2023)
IL-4 is a potential biomarker of DILI. Clinical diagnosis and understanding of DILI disease mechanisms may be improved by further investigation of novel biomarkers, and this IL-4 signal in serum is important as proof of concept for prospective study designs.
Keyphrases